Shine Lawyers is seeking patients for a potential class action against PPI manufacturers based on research suggesting long-term use is linked to gastric cancer and kidney injury. 

The firm says hundreds of Australians have already expressed interest in their investigation into esomeprazole, omeprazole, pantoprazole, rabeprazole and lansoprazole.